Veracyte, Inc. (VCYT) — Fair Value Analysis

Base-case fair value (P50): $41.37 · Current price: $41.25 · Verdict: Fairly Valued

The Verdict on VCYT

VERACYTE INC (VCYT) appears Fairly Valued based on our latest Monte Carlo simulations. The current market price of $41.25 closely aligns with the median fair value (P50) estimate of $41.37. This suggests that VCYT’s operational and financial health, while unrated against its sector, is appropriately reflected in its present valuation according to our forward-looking models. The slight +0.3% indicates minimal discrepancy between the market's assessment and our probabilistic P50 target, signaling equilibrium for VERACYTE INC at this juncture. Investors looking for a substantial discount or premium based on the median forecast will not find it here.

How VCYT stacks up against peers

VCYT's quality tier is currently unrated, with its sector designated as n/a, limiting direct comparative analysis against industry peers on traditional operational or financial health metrics. Despite the absence of a sector benchmark, our Monte Carlo framework provides an intrinsic valuation specific to VERACYTE INC, which pegs the median fair value at $41.37. This analysis considers VCYT’s own fundamentals and probabilistic future scenarios, independently arriving at a fair value that is largely in sync with its $41.25. The resulting +0.3% confirms that, even without a comparative quality tier, VCYT's individual valuation suggests it is not notably over or undervalued relative to its computed P50.

What this means for investors

For investors, the Fairly Valued verdict means VCYT's current price of $41.25 is largely consistent with its fundamental outlook. Our Monte Carlo simulations, which generate a P50 fair value of $41.37, imply that the market has efficiently priced the known information and likely future scenarios for VERACYTE INC. The negligible +0.3% suggests that while there isn't a significant immediate arbitrage opportunity based on the median outcome, the valuation is stable. FairCurve's detailed analysis provides the full probabilistic distribution, offering insights into potential downside and bull case scenarios. Sign up for a free FairCurve account to see VCYT's complete bear/bull distribution and track its fair value as new fundamentals are released.

Frequently Asked Questions

Is VCYT overvalued or undervalued right now?

Based on our Monte Carlo simulations, VERACYTE INC (VCYT) is Fairly Valued, with a median fair value (P50) of $41.37 against its current price of $41.25.

What is the bear case and bull case for VCYT?

The full Monte Carlo distribution, including bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values here.

How does FairCurve calculate VCYT's fair value?

FairCurve calculates VCYT's fair value using a sophisticated Monte Carlo simulation that models thousands of forward scenarios to generate a probabilistic range of outcomes and a median fair value estimate.

How can I track VCYT's fair value as it changes?

Add VCYT to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings or significant fundamental data are released.